Results 271 to 280 of about 181,456 (327)
Prevalence of Alloantibodies in Transfusion-dependent Thalassemia Patients
Neha Parashar +5 more
openalex +1 more source
Investigation on the Anxiety and Depression Status of Thalassemia Carriers After Genetic Counseling. [PDF]
Pan J, Xu A, Tung TH, Shen B.
europepmc +1 more source
Accurate diagnosis of hemoglobinopathies with machine learning based on high-throughput proteomics. [PDF]
Wei S +9 more
europepmc +1 more source
Frequency of Zinc Deficiency Among Thalassemia Major Patients: A Comparative Cross-Sectional Study. [PDF]
Hayat U +7 more
europepmc +1 more source
Assessment of β-Thalassemia Trait Occurrence in an Outpatient Sample from Southern Chile: A Retrospective Study. [PDF]
Balcázar-Villarroel M +9 more
europepmc +1 more source
Epidemiological study of thalassemia in the Buyi population of Qiannan Prefecture, Guizhou Province, China based on third-generation sequencing. [PDF]
Wu J +10 more
europepmc +1 more source
Beta-thalassemias are a group of hereditary blood disorders characterized by anomalies in the synthesis of the beta chains of hemoglobin resulting in variable phenotypes ranging from severe anemia to clinically asymptomatic individuals. The total annual incidence of symptomatic individuals is estimated at 1 in 100,000 throughout the world and 1 in 10 ...
Galanello R, ORIGA, RAFFAELLA
exaly +8 more sources
β-Thalassemia is caused by reduced (β+) or absent (β0) synthesis of the β-globin chains of hemoglobin. Three clinical and hematological conditions of increasing severity are recognized: the β-thalassemia carrier state, thalassemia intermedia, and thalassemia major, a severe transfusion-dependent anemia.
Raffaella Origa
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hematology, 2004
Abstract New developments in the epidemiology, treatment and prognosis of thalassemia have dramatically altered the approach to the care of affected patients, and these developments are likely to have an even greater impact in the next few years.
Alan R, Cohen +4 more
openaire +2 more sources
Abstract New developments in the epidemiology, treatment and prognosis of thalassemia have dramatically altered the approach to the care of affected patients, and these developments are likely to have an even greater impact in the next few years.
Alan R, Cohen +4 more
openaire +2 more sources

